Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3027050 | Thrombosis Research | 2016 | 4 Pages |
Abstract
•Review of prospective RCT's on aspirin for venous thromboembolism (VTE)•Aspirin at 80–250 mg/day reduces relative risk on VTE after orthopedic surgery.•Aspirin doses 600–1300 mg/day or 2000–3000 mg/day seem less effective or worse.•Such high aspirin doses block endogenous platelet inhibition (by e.g. PGI2).
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Piet Borgdorff, Geert Jan Tangelder,